← Open Payments lookup

STEPHEN BROWN: Open Payments

NPI 1053464420 · LYNWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,713 in 84 payments from 10 companies in 2025. Trend: 2023 $1,956 · 2024 $2,792 · 2025 $2,713

Food & beverage: $2,713
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.17$605
Teva Pharmaceuticals USA, Inc.15$508
E.R. Squibb & Sons, L.L.C.16$481
Janssen Pharmaceuticals, Inc15$456
Otsuka America Pharmaceutical, Inc.7$244
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$223
Lundbeck LLC3$75
Vanda Pharmaceuticals Inc.3$58
Luye Pharma (USA) Ltd.2$40
Alkermes, Inc.1$23

Products named: INGREZZA, UZEDY, INVEGA SUSTENNA, COBENFY, CAPLYTA, ABILIFY MAINTENA, FANAPT, REXULTI.

Industry payments across CA — which companies pay providers there.